Rationale for the clinical application of flow cytometry in patients with myelodysplastic syndromes: Position paper of an International Consortium and the European LeukemiaNet Working Group

Arjan A. Van De Loosdrecht, Robin Ireland, Wolfgang Kern, Matteo G. Della Porta, Canan Alhan, Jan Sebastian Balleisen, Peter Bettelheim, David T. Bowen, Kate Burbury, Lisa Eidenschink, Mario Cazzola, Spencer S C Chu, Matthew Cullen, Jevon A. Cutler, Angelika M. Dräger, Jean Feuillard, Pierre Fenaux, Patricia Font, Ulrich Germing, Detlef HaaseEva Hellström-Lindberg, Ulrika Johansson, Shahram Kordasti, Michael R. Loken, Luca Malcovati, Jeroen G. Te Marvelde, Sergio Matarraz, Timothy Milne, Bijan Moshaver, Ghulam J. Mufti, Veselka Nikolova, Kiyoyuki Ogata, Uta Oelschlaegel, Alberto Orfao, Gert J. Ossenkoppele, Anna Porwit, Uwe Platzbecker, Frank Preijers, Katherina Psarra, Stephen J. Richards, Dolores Subirá, John F. Seymour, Vicky Tindell, Teresa Vallespi, Peter Valent, Vincent H J Van Der Velden, Denise A. Wells, Theo M. De Witte, Florian Zettl, Marie C. Béné, Theresia M. Westers

Research output: Contribution to journalArticle

Abstract

An international working group within the European LeukemiaNet gathered, aiming to determine the role of flow cytometry (FC) in myelodysplastic syndromes (MDS). It was agreed that FC has a substantial application in disease characterization, diagnosis and prognosis. FC may also be useful in predicting treatment responses and monitoring novel and standard therapeutic regimens. In this article the rationale is discussed that flow cytometry should be integrated as a part of diagnostic and prognostic scoring systems in MDS.

Original languageEnglish
Pages (from-to)472-475
Number of pages4
JournalLeukemia and Lymphoma
Volume54
Issue number3
DOIs
Publication statusPublished - Mar 2013

    Fingerprint

Keywords

  • Consensus
  • ELN
  • Flow cytometry
  • Myelodysplastic syndromes

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Van De Loosdrecht, A. A., Ireland, R., Kern, W., Della Porta, M. G., Alhan, C., Balleisen, J. S., Bettelheim, P., Bowen, D. T., Burbury, K., Eidenschink, L., Cazzola, M., Chu, S. S. C., Cullen, M., Cutler, J. A., Dräger, A. M., Feuillard, J., Fenaux, P., Font, P., Germing, U., ... Westers, T. M. (2013). Rationale for the clinical application of flow cytometry in patients with myelodysplastic syndromes: Position paper of an International Consortium and the European LeukemiaNet Working Group. Leukemia and Lymphoma, 54(3), 472-475. https://doi.org/10.3109/10428194.2012.718341